High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

NCT03007823 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: High-activity natural killer

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]